Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Bronchopulmonary Disease (BPD) Patient Registry (CHILD)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified August 2009 by Boston Children’s Hospital.
Recruitment status was  Recruiting
Information provided by:
Boston Children’s Hospital Identifier:
First received: August 3, 2009
Last updated: NA
Last verified: August 2009
History: No changes posted
The goal of the Bronchopulmonary Dysplasia (BPD) Patient Registry is to collect data on individuals with neonatal lung disease to better understand the illness and ultimately improve their care and survival. The Patient Registry was established in 2008 as a means to monitor important trends in the BPD population and to improve understanding, treatment, and survival.

Condition Intervention
Bronchopulmonary Disease
Other: Patient Registry

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Prospective
Official Title: The Center for Healthy Infant Development (Child) Clinic Patient Registry

Further study details as provided by Boston Children’s Hospital:

Estimated Enrollment: 360
Study Start Date: June 2008
Groups/Cohorts Assigned Interventions
Bronchopulmonary Dysplasia (BPD) Other: Patient Registry
The BPD Patient Registry is used by both clinicians and researchers to better understand BPD and to improve care of individuals with BPD.

Detailed Description:
The BPD Patient Registry is used by both clinicians and researchers to better understand BPD and to improve care of individuals with BPD. Each year the data in the Patient Registry will be analyzed and an annual report of BPD health trends will be created. Using this information, BPD clinicians can address quality improvement initiatives, and examine changing health care issues, including nutritional status, infection control, pulmonary treatment and/or metabolic issues rapidly and effectively. The Patient Registry will also play an important role in directing clinical care and in the design of clinical research studies. Researchers use the registry to help in investigating various aspects of neonatal lung diseases like BPD, including medications, diagnostic procedures, and eligibility for clinical trials.

Ages Eligible for Study:   up to 12 Years   (Child)
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Bronchopulmonary Dysplasia (BPD) patients will be approached during clinical visit and inpatient hospitalizations.

Inclusion Criteria:

  • Bronchopulmonary Dysplasia (BPD)
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00951366

United States, Massachusetts
Children's Hosptital, Boston Recruiting
Boston, Massachusetts, United States, 02115
Contact: Lawrence Rhein, MD    617-355-3185   
Principal Investigator: Lawrence Rhein, MD         
Sponsors and Collaborators
Boston Children’s Hospital
  More Information

Responsible Party: Lawrence Rhein, MD, Children's Hospital, Boston Identifier: NCT00951366     History of Changes
Other Study ID Numbers: X08-07-0335 
Study First Received: August 3, 2009
Last Updated: August 3, 2009
Health Authority: United States: Institutional Review Board

Keywords provided by Boston Children’s Hospital:
For clinicians and researchers to better understand BPD
To improve care of individuals with BPD
To examine quality improvement initiatives
To examine changing health care issues
To determine eligibility of clinical research studies processed this record on October 21, 2016